COMPANY PROFILE // THE 014 REPORT
enVVeno Medical Corp
NVNO (Nasdaq) · Formerly: Hancock Jaffe Laboratories, Inc.
Assembled from 3 government sources in 0.2 s
FLAGS · DISCLOSURE · SUMMARY
Missing or hidden
- AmberGLEIF: the direct parent is not reported; reporting exception filed with reason NON_PUBLIC.
- AmberLEI 549300KF5KREFECSNV87 registration status is LAPSED (last update 2026-08-11): the legal-entity record has not been renewed.
- Amber8-K Item 3.01 filed: notice of delisting, of a failed continued-listing rule, or of a transfer of listing on 2025-10-10 (last 24 months).
- Amber8-K Item 4.01 filed: change in the company's certifying accountant (auditor) on 2025-04-21 (last 24 months).
✓ SEC filings✓ LEI✗ SAM registration✗ IRS return✗ State registration✗ Website✗ Lobbying registration
No SAM registration, no IRS return, no state registration, no website, no lobbying registration on record.
enVVeno Medical Corp is an SEC-registered operating company in surgical & medical instruments & apparatus, incorporated in DE, based in Irvine, CA; listed as NVNO (Nasdaq).[source] It has filed 39 documents with the SEC in the last 12 months; the latest is a SCHEDULE 13G/A, filed 2026-11-10.[source] Its largest institutional holders on 13F filings are KINGDON CAPITAL MANAGEMENT, L.L.C., CM Management, LLC, VANGUARD CAPITAL MANAGEMENT LLC (as of 2026-06-30).[source] Seraphix flags 4 items from these records: 8-K Item 4.01 filed; 8-K Item 3.01 filed; LEI 549300KF5KREFECSNV87 registration status is LAPSED (last update 2026-08-11).[source]
- red0
- amber4
- info0
- KINGDON CAPITAL MANAGEMENT, L.L.C.$387K
- CM Management, LLC$382K
- VANGUARD CAPITAL MANAGEMENT LLC$67K
- JPMORGAN CHASE & CO$59K
- VANGUARD FIDUCIARY TRUST CO$23K
- Westside Investment Management, Inc.$16K
- Mirae Asset Global Investments Co., Ltd.$6K
- BlackRock, Inc.$4K
RECORD · WEB
Ask about this entity
Answers come from this 014 first; every line is marked RECORD (our record, linked) or WEB (a web page, credited and linked).
PEOPLE · COUNSEL · LINKS
Leadership, advisers and links
Officers and directors (Forms 3, 4, 5)
- Alavi Hamed · Chief Technology Officer (Officer) · latest Form 4 2025-12-18 · filing · LinkedIn search
- BERMAN ROBERT ANDREW · Chief Executive Officer (Director,Officer) · latest Form 4 2025-12-18 · filing · LinkedIn search
- Bright Jennifer · Chief Financial Officer (Officer) · latest Form 4 2025-05-20 · filing · LinkedIn search
- Glickman Marc H. · SVP & Chief Medical Officer (Officer) · latest Form 4 2025-12-18 · filing · LinkedIn search
- Duhay Francis · Director · latest Form 4 2026-03-13 · filing · LinkedIn search
- Gray Robert · Director · latest Form 4 2025-12-15 · filing · LinkedIn search
- Jenusaitis Matthew · Director · latest Form 4 2025-12-15 · filing · LinkedIn search
- Shrivastava Sanjay · Director · latest Form 4 2025-12-15 · filing · LinkedIn search
As reported to the SEC by the insiders themselves; SEC insider transactions data sets (Forms 3, 4, 5): 2026q1, 2025q4, 2025q3, 2025q2.
EVERY LIST AND SOURCE · DATED
Checked and clear
26 lists and sources checked: 26 CLEAR, 0 POSSIBLE MATCH, 0 MATCH. Screening lists are checked when this 014 is built; the enforcement and registry sources at the last company-engine build. Each date is the date of that check.
EVERY IDENTIFIER · LINKED
ID crosswalk
| Identifier | Value | Record |
|---|---|---|
| SEC CIK | 0001661053 | source |
| LEI | 549300KF5KREFECSNV87 | source |
| EIN | 33-0936180 | source |
| Business address (SEC) | 70 DOPPLER, IRVINE, CA, 92618 | source |
Does not exist in the records we hold: UEI, NY DOS ID, FDIC certificate.
EACH FEEDS WATCH
Dates coming up
- 2018-10-06 · in -2,967 days · LEI next renewal (549300KF5KREFECSNV87)
- 2027-03-31 · in 131 days · Next 10-K due (period ended 2026-12-31; Non-accelerated filer<br>Smaller reporting company) (computed from the fiscal year end and filer status)
- 2027-05-15 · in 176 days · Next 10-Q due (period ended 2027-03-31; Non-accelerated filer<br>Smaller reporting company) (computed from the fiscal year end and filer status)
PEERS BY SIC CODE
Industry context
SIC 3841 (surgical & medical instruments & apparatus): 149 companies in our records share this code.
federal dollars
lobbying filings
SEC filings in 12 months
flags
Peers, each with its 014
- STRYKER CORP · 101 SEC filings in 12 months · 1 flag · $502.2M federal (possible match)
- ORASURE TECHNOLOGIES INC · 69 SEC filings in 12 months · 2 flags · $480.7M federal (possible match)
- 3M CO · 124 SEC filings in 12 months · $465.5M federal (possible match)
- BOSTON SCIENTIFIC CORP · 110 SEC filings in 12 months · 1 flag · $140.1M federal (possible match)
- CERUS CORP · 71 SEC filings in 12 months · 2 flags · $126.6M federal (possible match)
- BAXTER INTERNATIONAL INC · 84 SEC filings in 12 months · 1 flag · $54.7M federal (possible match)
- Inspire Medical Systems, Inc. · 100 SEC filings in 12 months · 4 flags · $22.3M federal (possible match)
- ACCURAY INC · 103 SEC filings in 12 months · 4 flags · $13.9M federal (possible match)
- NeuroPace Inc · 61 SEC filings in 12 months · $10.3M federal (possible match)
- TELEFLEX INC · 64 SEC filings in 12 months · 1 flag · $9.4M federal (possible match)
- Cytosorbents Corp · 30 SEC filings in 12 months · 4 flags · $5.0M federal (possible match)
- IRADIMED CORP · 70 SEC filings in 12 months · 1 flag · $4.0M federal (possible match)
EVERY SOURCE · NEWEST FIRST
One timeline
- 2026-10-29 filing DEFA14A · SEC EDGAR
- 2026-10-29 filing Proxy statement · SEC EDGAR
- 2026-10-29 filing Quarterly report (10-Q) · SEC EDGAR
- 2026-09-15 filing SCHEDULE 13D/A · SEC EDGAR
- 2026-09-11 filing 144 · SEC EDGAR
- 2026-08-21 filing S-3 · SEC EDGAR
- 2026-07-30 filing Quarterly report (10-Q) · SEC EDGAR
- 2026-07-14 filing 8-K items 7.01,9.01 · SEC EDGAR
- 2026-06-11 filing 144 · SEC EDGAR
- 2026-05-06 filing Quarterly report (10-Q) · SEC EDGAR
- 2026-04-29 filing 8-K items 2.02,7.01,8.01,9.01 · SEC EDGAR
- 2026-03-26 filing S-8 · SEC EDGAR
- 2026-03-26 filing Annual report (10-K) · SEC EDGAR
- 2026-03-12 filing 144 · SEC EDGAR
- 2026-02-20 filing SCHEDULE 13D · SEC EDGAR
- 2026-02-20 filing SCHEDULE 13D · SEC EDGAR
- 2026-02-04 filing 8-K items 2.02,8.01,9.01 · SEC EDGAR
- 2026-01-20 filing 8-K items 5.03,9.01 · SEC EDGAR
- 2025-12-18 insider First Form 3/4/5 on record for Alavi Hamed (Chief Technology Officer) · SEC Forms 3/4/5
- 2025-12-18 insider First Form 3/4/5 on record for BERMAN ROBERT ANDREW (Chief Executive Officer) · SEC Forms 3/4/5
- 2025-12-18 insider First Form 3/4/5 on record for Glickman Marc H. (SVP & Chief Medical Officer) · SEC Forms 3/4/5
- 2025-12-15 insider First Form 3/4/5 on record for Gray Robert (Director) · SEC Forms 3/4/5
- 2025-12-15 insider First Form 3/4/5 on record for Jenusaitis Matthew (Director) · SEC Forms 3/4/5
- 2025-12-15 insider First Form 3/4/5 on record for Shrivastava Sanjay (Director) · SEC Forms 3/4/5
- 2025-12-12 filing 8-K items 5.07,9.01 · SEC EDGAR
- 2025-12-02 filing DEFR14A · SEC EDGAR
- 2025-11-20 filing 8-K items 5.03,9.01 · SEC EDGAR
- 2025-11-19 filing PRER14A · SEC EDGAR
- 2025-11-14 filing 8-K items 7.01,9.01 · SEC EDGAR
- 2025-10-30 filing 8-K items 1.01,9.01 · SEC EDGAR
170 earlier entries
- 2025-10-30 filing 424B5
- 2025-10-30 filing DEFA14A
- 2025-10-30 filing Proxy statement
- 2025-10-30 filing Quarterly report (10-Q)
- 2025-10-10 filing 8-K items 3.01,9.01
- 2025-09-17 insider First Form 3/4/5 on record for Duhay Francis (Director)
- 2025-09-15 filing 144
- 2025-08-20 filing 8-K items 7.01,9.01
- 2025-07-31 filing Quarterly report (10-Q)
- 2025-05-20 officer change 8-K items 5.02,9.01
- 2025-05-20 insider First Form 3/4/5 on record for Bright Jennifer (Chief Financial Officer)
- 2025-04-30 filing Quarterly report (10-Q)
- 2025-04-21 filing 8-K items 4.01,9.01
- 2025-03-14 filing EFFECT
- 2025-03-14 filing CORRESP
- 2025-03-12 filing S-8
- 2025-03-12 filing S-3/A
- 2025-03-10 filing UPLOAD
- 2025-02-28 filing S-3
- 2025-02-28 filing 10-K/A
- 2025-02-28 filing Annual report (10-K)
- 2024-12-26 filing 8-K items 5.07
- 2024-11-19 filing Proxy statement
- 2024-10-31 filing Quarterly report (10-Q)
- 2024-09-30 filing 8-K items 1.01,9.01
- 2024-09-30 filing 424B5
- 2024-09-27 filing FWP
- 2024-09-26 filing 424B5
- 2024-07-31 filing Quarterly report (10-Q)
- 2024-05-10 filing S-8
- 2024-05-08 filing Quarterly report (10-Q)
- 2024-04-24 filing 8-K items 7.01,9.01
- 2024-03-06 filing 8-K items 7.01,9.01
- 2024-02-29 filing Annual report (10-K)
- 2023-12-07 filing 8-K items 5.07
- 2023-11-16 filing 8-K items 7.01,9.01
- 2023-11-03 filing EFFECT
- 2023-11-03 filing Proxy statement
- 2023-11-01 filing CORRESP
- 2023-10-31 filing UPLOAD
- 2023-10-26 filing S-3
- 2023-10-26 filing Quarterly report (10-Q)
- 2023-10-12 filing 8-K items 1.01,3.02,9.01
- 2023-08-23 filing EFFECT
- 2023-08-21 filing CORRESP
- 2023-08-14 filing S-3/A
- 2023-08-07 filing UPLOAD
- 2023-07-31 filing S-3
- 2023-07-31 filing Quarterly report (10-Q)
- 2023-05-26 filing 25-NSE
- 2023-05-05 filing 424B3
- 2023-04-28 filing Quarterly report (10-Q)
- 2023-03-02 filing Annual report (10-K)
- 2022-12-06 filing 8-K items 5.07
- 2022-11-01 filing Proxy statement
- 2022-10-27 filing Quarterly report (10-Q)
- 2022-08-03 filing Quarterly report (10-Q)
- 2022-05-16 filing UPLOAD
- 2022-05-11 filing 10-Q/A
- 2022-05-11 filing 10-K/A
- 2022-05-11 filing CORRESP
- 2022-05-06 filing UPLOAD
- 2022-04-29 filing Quarterly report (10-Q)
- 2022-04-18 filing S-8
- 2022-03-28 filing Annual report (10-K)
- 2021-12-03 filing 8-K/A items 5.07
- 2021-12-01 filing 8-K items 5.07,7.01
- 2021-11-12 filing Quarterly report (10-Q)
- 2021-11-02 filing Proxy statement
- 2021-10-01 filing 8-K items 5.03,9.01
- 2021-09-22 filing 8-K items 8.01,9.01
- 2021-09-22 name change Name changed from Hancock Jaffe Laboratories, Inc.
- 2021-09-08 filing 8-K items 1.01,9.01
- 2021-09-08 filing 424B5
- 2021-08-12 filing 8-K items 1.01,9.01
- 2021-08-12 filing 424B5
- 2021-08-11 filing Quarterly report (10-Q)
- 2021-08-06 filing 424B3
- 2021-05-26 filing S-8
- 2021-05-12 filing Quarterly report (10-Q)
- 2021-05-06 filing EFFECT
- 2021-04-30 filing POS AM
- 2021-03-31 filing Annual report (10-K)
- 2021-02-24 officer change 8-K items 5.02
- 2021-02-12 filing 8-K items 1.01,8.01,9.01
- 2021-02-10 filing 424B4
- 2021-02-08 filing EFFECT
- 2021-02-08 filing S-1MEF
- 2021-02-05 filing CORRESP
- 2021-02-05 filing CORRESP
- 2021-02-05 filing FWP
- 2021-02-05 filing S-1/A
- 2021-02-04 filing CORRESP
- 2021-02-03 filing CORRESP
- 2021-02-03 filing CORRESP
- 2021-02-03 filing S-1/A
- 2021-01-29 filing FWP
- 2021-01-28 filing S-1/A
- 2020-12-28 filing UPLOAD
- 2020-12-21 filing 8-K items 5.07,8.01,9.01
- 2020-12-21 filing Registration (S-1)
- 2020-12-18 filing SC 13D/A
- 2020-12-16 filing SC 13D
- 2020-12-02 filing 8-K items 5.03,9.01
- 2020-11-30 filing EFFECT
- 2020-11-27 filing CORRESP
- 2020-11-24 filing 8-K items 3.02
- 2020-11-24 filing S-1/A
- 2020-11-17 filing Quarterly report (10-Q)
- 2020-11-17 filing NT 10-Q
- 2020-11-13 filing Proxy statement
- 2020-11-12 filing UPLOAD
- 2020-11-06 filing Registration (S-1)
- 2020-10-22 filing EFFECT
- 2020-10-20 filing CORRESP
- 2020-10-08 filing 424B5
- 2020-10-08 filing 8-K items 1.01,3.02,9.01
- 2020-10-05 filing S-3/A
- 2020-09-24 filing UPLOAD
- 2020-09-17 filing S-3
- 2020-09-16 filing 8-K items 5.03,5.07,9.01
- 2020-08-19 filing DEFA14A
- 2020-08-14 filing Quarterly report (10-Q)
- 2020-08-13 filing UPLOAD
- 2020-08-12 filing Proxy statement
- 2020-08-10 filing CORRESP
- 2020-08-10 filing UPLOAD
- 2020-08-07 filing 144
- 2020-08-04 filing D
- 2020-07-24 filing PRE 14A
- 2020-07-21 filing 8-K items 1.01,3.02,5.03,8.01,9.01
- 2020-07-20 filing 424B4
- 2020-07-16 filing EFFECT
- 2020-07-16 filing S-1/A
- 2020-07-15 filing CORRESP
- 2020-07-15 filing CORRESP
- 2020-07-13 filing FWP
- 2020-07-13 filing S-1/A
- 2020-07-09 filing 144
- 2020-07-08 filing UPLOAD
- 2020-07-02 filing Registration (S-1)
- 2020-06-23 filing EFFECT
- 2020-06-22 filing CORRESP
- 2020-06-19 filing UPLOAD
- 2020-06-15 filing Registration (S-1)
- 2020-06-15 filing 8-K items 8.01
- 2020-06-08 filing Quarterly report (10-Q)
- 2020-06-08 filing 144
- 2020-06-03 filing 8-K items 1.01,3.02,9.01
- 2020-06-03 filing 424B5
- 2020-05-15 filing 8-K items 8.01
- 2020-05-08 filing 144
- 2020-04-28 filing 8-K items 1.01,3.02,9.01
- 2020-04-28 filing 424B5
- 2020-04-20 filing 8-K items 3.01
- 2020-04-16 filing EFFECT
- 2020-04-15 filing CORRESP
- 2020-04-14 filing UPLOAD
- 2020-04-10 officer change 8-K items 5.02
- 2020-04-07 filing S-3
- 2020-04-03 officer change 8-K items 5.02
- 2020-03-25 filing 8-K items 3.01
- 2020-03-18 filing Annual report (10-K)
- 2020-03-10 filing D
- 2020-03-05 filing 144
- 2020-03-02 filing 8-K items 3.02,9.01
- 2019-12-11 filing 8-K items 5.07
- 2019-10-31 filing Quarterly report (10-Q)
- 2019-10-29 filing Proxy statement
- 2019-10-25 filing 8-K items 7.01,9.01
RENDERED FROM THIS PAGE
Relationship graph
Holders from 13F filings, subsidiaries from the GLEIF tree (by LEI), lobbying firms from LDA (possible match), agencies from USAspending, people from Forms 3/4/5, counsel from Exhibit 5.1, shared boards from Forms 3/4/5.
DATA MOTION // NEWEST FIRSTWhat changed
- 2026-10-29 (within 30 days) DEFA14A filed
- 2026-10-29 (within 30 days) DEF 14A filed
- 2026-10-29 (within 30 days) 10-Q filed
- 2026-08-21 (older) S-3 filed
- 2026-07-30 (older) 10-Q filed
- 2026-07-14 (older) 8-K filed: Item 7.01 Regulation FD disclosure; Item 9.01 exhibits
- 2026-05-06 (older) 10-Q filed
- 2026-04-29 (older) 8-K filed: Item 2.02 results of operations; Item 7.01 Regulation FD disclosure; Item 8.01 other event; Item 9.01 exhibits
Dot rule: red = within 7 days, amber = within 30 days, green = older. Measured against 2026-11-20; the colour is also written out in words.
COUNTS FROM THIS PAGERelationships at a glance
PRICE · FILINGS · POSTS · NEWSMarket & news
- Price
- NASDAQ:NVNO The chart widget (TradingView) shows the price and the previous session's close. Seraphix publishes no price of its own.
- Open in
Open in…
Price and chart
News
Analyst estimates and earnings
Institutional holders
Short interest
Official social
Each link opens the other site in a new tab, with this company filled in. That site shows its own data under its own terms; Seraphix stores none of it. Seraphix counts clicks per link, nothing about who clicked.
- Financials
- Filed figures: published SEC values, each linked to its filing.
- Official posts
- Links to posts from the company's and agencies' verified accounts: not connected yet.
- News
- Article links (headline, date, link): not connected yet.
EVERY RESOLVED IDENTIFIER1. Identity
0 possible matches held apart, matched by name only, not counted above; 3 records under a former name, shown apart.
| Identifier | Value | How it was resolved | Source |
|---|---|---|---|
| SEC CIK | 1661053 | id:sec-anchor: the SEC registrant record of this company | SEC EDGAR |
| Ticker / exchange | NVNO / Nasdaq | SEC company record: ticker and exchange as listed on the SEC company record | SEC EDGAR |
| LEI (root of the ownership tree) | 549300KF5KREFECSNV87 | id:lei-family: legal entity in this company's GLEIF ownership tree (LEI 549300KF5KREFECSNV87) | GLEIF |
| EIN | 330936180 | carried on the SEC-anchored record: listed in the identifiers of sx:sec:0001661053 | SEC EDGAR / IRS |
| CUSIP | 29415J205 | carried on the SEC-anchored record: listed in the identifiers of sx:sec:0001661053 | SEC EDGAR |
former name (shown apart, not merged) (3)
- former nameHANCOCK JAFFE LABORATORIES, INC. · State licences
- former nameHANCOCK JAFFE LABORATORIES, INC. · State licences
- former nameHANCOCK JAFFE LABORATORIES INC · EPA ECHO facilities
AS FILED · EACH WITH ITS DATE AND FILING2. Filed figures
Key figures (annual filing)
| Figure | Value | Period or as of | Source | Basis | Retrieved | Report |
|---|---|---|---|---|---|---|
| Net income (loss) (fiscal year ended 2025-12-31) | -$19,472,000 | 2025-12-31 | 10-K, XBRL NetIncomeLoss | as filed | 2026-11-20 09:09 UTC | Report an error |
| Total assets (at 2025-12-31) | $29,562,000 | 2025-12-31 | 10-K, XBRL Assets | as filed | 2026-11-20 09:09 UTC | Report an error |
| Stockholders' equity (at 2025-12-31) | $27,130,000 | 2025-12-31 | 10-K, XBRL StockholdersEquity | as filed | 2026-11-20 09:09 UTC | Report an error |
| Cash and cash equivalents (at 2025-12-31) | $3,065,000 | 2025-12-31 | 10-K, XBRL CashAndCashEquivalentsAtCarryingValue | as filed | 2026-11-20 09:09 UTC | Report an error |
Company profile facts (SEC)
| Figure | Value | Period or as of | Source | Basis | Retrieved | Report |
|---|---|---|---|---|---|---|
| SEC entity type | operating | 2026-11-10 | SEC EDGAR company profile | as filed | 2026-11-20 09:09 UTC | Report an error |
| SIC industry | 3841 Surgical & Medical Instruments & Apparatus | 2026-11-10 | SEC EDGAR company profile | as filed | 2026-11-20 09:09 UTC | Report an error |
| State of incorporation | DE | 2026-11-10 | SEC EDGAR company profile | as filed | 2026-11-20 09:09 UTC | Report an error |
| Fiscal year end (MMDD) | 1231 | 2026-11-10 | SEC EDGAR company profile | as filed | 2026-11-20 09:09 UTC | Report an error |
| Business address | 70 DOPPLER, IRVINE, CA, 92618 | 2026-11-10 | SEC EDGAR company profile | as filed | 2026-11-20 09:09 UTC | Report an error |
| Exchanges | Nasdaq | 2026-11-10 | SEC EDGAR company profile | as filed | 2026-11-20 09:09 UTC | Report an error |
Other filed values
| Figure | Value | Period or as of | Source | Basis | Retrieved | Report |
|---|---|---|---|---|---|---|
| Operating cash flow (fiscal year ended 2025-12-31) | -$15,568,000 | 2025-12-31 | 10-K, XBRL NetCashProvidedByUsedInOperatingActivities | as filed | 2026-11-20 09:09 UTC | Report an error |
| Capital expenditures (property, plant and equipment) (fiscal year ended 2025-12-31) | $5,000 | 2025-12-31 | 10-K, XBRL PaymentsToAcquirePropertyPlantAndEquipment | as filed | 2026-11-20 09:09 UTC | Report an error |
| Operating lease liabilities (at 2025-12-31) | $700,000 | 2025-12-31 | 10-K, XBRL OperatingLeaseLiability | as filed | 2026-11-20 09:09 UTC | Report an error |
| Form D total offering amount (D filed 2020-08-04) | $1,556,000 | 2020-08-04 | D | as filed | 2026-11-20 09:09 UTC | Report an error |
| Form D total amount sold (D filed 2020-08-04) | $1,556,000 | 2020-08-04 | D | as filed | 2026-11-20 09:09 UTC | Report an error |
| Form D industry group | Biotechnology | 2020-08-04 | D | as filed | 2026-11-20 09:09 UTC | Report an error |
| Form D revenue range | Decline to Disclose | 2020-08-04 | D | as filed | 2026-11-20 09:09 UTC | Report an error |
| Form D date of first sale | 2020-07-21 | 2020-08-04 | D | as filed | 2026-11-20 09:09 UTC | Report an error |
Latest report: 10-Q for the period ended 2026-09-30, filed 2026-10-29 · accession 0001493152-26-049269
| Item | Value | Period | Form | Filed | Accession | Retrieved | Report |
|---|---|---|---|---|---|---|---|
| Net income (loss) | -$4,367,000 | 3 months ended 2026-09-30 | 10-Q | 2026-10-29 | 0001493152-26-049269 | 2026-11-20 09:09 UTC | Report an error |
| Cash and cash equivalents | $2,585,000 | at 2026-09-30 | 10-Q | 2026-10-29 | 0001493152-26-049269 | 2026-11-20 09:09 UTC | Report an error |
Values as filed in XBRL (SEC company facts); quarterly values are the filer's own 3-month figures, never derived.
No estimates: every value is as filed and links to the filing it came from.
Registration: the SEC filer status is under "Company profile facts (SEC)" above. SAM.gov registration status: not held yet.
NEWEST FIRST · EACH LINKS TO ITS FILING3. Registration and filing timeline
- 2026-10-29 Filing DEFA14A filed
- 2026-10-29 Filing DEF 14A filed
- 2026-10-29 Filing 10-Q filed
- 2026-08-21 Filing S-3 filed
- 2026-07-30 Filing 10-Q filed
- 2026-07-14 Filing 8-K filed: Item 7.01 Regulation FD disclosure; Item 9.01 exhibits
- 2026-05-06 Filing 10-Q filed
- 2026-04-29 Filing 8-K filed: Item 2.02 results of operations; Item 7.01 Regulation FD disclosure; Item 8.01 other event; Item 9.01 exhibits
- 2026-03-26 Filing S-8 filed
- 2026-03-26 Filing 10-K filed
- 2026-02-04 Filing 8-K filed: Item 2.02 results of operations; Item 8.01 other event; Item 9.01 exhibits
- 2026-01-20 Filing 8-K filed: Item 5.03 charter or bylaw amendment; Item 9.01 exhibits
- 2025-12-12 Filing 8-K filed: Item 5.07 shareholder vote; Item 9.01 exhibits
- 2025-12-02 Filing DEFR14A filed
- 2025-11-20 Filing 8-K filed: Item 5.03 charter or bylaw amendment; Item 9.01 exhibits
- 2025-11-19 Filing PRER14A filed
- 2025-11-14 Filing 8-K filed: Item 7.01 Regulation FD disclosure; Item 9.01 exhibits
- 2025-10-30 Filing 8-K filed: Item 1.01 material agreement; Item 9.01 exhibits
- 2025-10-30 Filing 424B5 filed
- 2025-10-30 Filing DEFA14A filed
- 2025-10-30 Filing DEF 14A filed
- 2025-10-30 Filing 10-Q filed
- 2025-10-10 Filing 8-K filed: Item 3.01 delisting notice; Item 9.01 exhibits
- 2025-08-20 Filing 8-K filed: Item 7.01 Regulation FD disclosure; Item 9.01 exhibits
- 2025-07-31 Filing 10-Q filed
AS FILED · LARGEST HOLDERS10. 13F institutional holders
| Rank | Holder (13F filer) | Value held | As of | Source | Retrieved | Report |
|---|---|---|---|---|---|---|
| 1 | KINGDON CAPITAL MANAGEMENT, L.L.C. | $387,338 | 2026-06-30 | SEC 13F filing | 2026-11-20 09:09 UTC | Report an error |
| 2 | CM Management, LLC | $382,497 | 2026-06-30 | SEC 13F filing | 2026-11-20 09:09 UTC | Report an error |
| 3 | VANGUARD CAPITAL MANAGEMENT LLC | $67,397 | 2026-06-30 | SEC 13F filing | 2026-11-20 09:09 UTC | Report an error |
| 4 | JPMORGAN CHASE & CO | $59,111 | 2026-06-30 | SEC 13F filing | 2026-11-20 09:09 UTC | Report an error |
| 5 | VANGUARD FIDUCIARY TRUST CO | $23,412 | 2026-06-30 | SEC 13F filing | 2026-11-20 09:09 UTC | Report an error |
| 6 | Westside Investment Management, Inc. | $16,332 | 2026-06-30 | SEC 13F filing | 2026-11-20 09:09 UTC | Report an error |
| 7 | Mirae Asset Global Investments Co., Ltd. | $5,773 | 2026-06-30 | SEC 13F filing | 2026-11-20 09:09 UTC | Report an error |
| 8 | BlackRock, Inc. | $4,434 | 2026-06-30 | SEC 13F filing | 2026-11-20 09:09 UTC | Report an error |
| 9 | Tower Research Capital LLC (TRC) | $3,545 | 2026-06-30 | SEC 13F filing | 2026-11-20 09:09 UTC | Report an error |
| 10 | WELLS FARGO & COMPANY/MN | $1,221 | 2026-06-30 | SEC 13F filing | 2026-11-20 09:09 UTC | Report an error |
13F as filed: the holder's own report of its position value at the quarter end.
GLEIF OWNERSHIP TREE · ID TIER11. Subsidiaries
1 legal entity in the company's GLEIF ownership tree, joined by LEI (an official identifier).
- ENVVENO MEDICAL CORPORATION · LEI 549300KF5KREFECSNV87 · root
Exhibit 21 subsidiaries: not held yet.
WHAT THIS PAGE READ
Sources
JSON · MCP · API
API and agents
The same profile as JSON: GET /company/1661053.json. The MCP server and the records API return the same data: GET /v1/record/sx:sec:0001661053. Every source URL used is listed in the file.
Get the evidence file, alerts and the API with a free key. Everything on this page stays free to read.